A year ago, after much fanfare and controversy, the Food and Drug Administration approved Eisai and Biogen’s lecanemab, an anti-amyloid drug that moderately slowed cognitive
What You Should Know: – PreciseDx, a pioneering company in oncology diagnostics utilizing artificial intelligence (AI) raises $20.7M in Series B funding led by Eventide
What You Should Know: – Upstart technology innovator Piramidal has secured $6 million in seed funding to aid its development of a barrier-breaking artificial intelligence (AI)
What You Should Know: – Ciba Health, a digital health company transforming healthcare with root-cause medicine and leveraging cutting-edge technology AI/ML, announced today its launch
Dive Brief: Zoll said Monday it has agreed to acquire Vyaire Medical’s ventilator business after winning an auction of the assets. Vyaire held a virtual
Listen to the article 5 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: The Food and Drug Administration
Dive Brief: Masimo said last week that new potential acquirers have shown interest in its consumer audio brands. The would-be suitors emerged as Masimo conducted
Merck’s Ebola vaccine offered substantial protection to people vaccinated during the 2018-2020 outbreak in the Democratic Republic of the Congo, with an effectiveness of 84%
In recent years, machine learning models have become increasingly popular for risk assessment of chemical compounds.
Pharma companies seeking to commercialise mRNA should consider partnering with an expert material supplier today. In the wake of the Covid-19 vaccine, mRNA research and